Truist Financial Maintains American Well(AMWL.US) With Hold Rating
Truist Financial Keeps Their Hold Rating on American Well (AMWL)
TD Cowen Maintains American Well(AMWL.US) With Hold Rating, Maintains Target Price $12
A Quick Look at Today's Ratings for American Well(AMWL.US), With a Forecast Between $12 to $20
TD Cowen Sticks to Its Hold Rating for American Well (AMWL)
American Well (AMWL) Progresses With Caution: Hold Rating Maintained Pending Financial Outlook Confirmation
American Well Analyst Ratings
Analysts Conflicted on These Healthcare Names: American Well (AMWL), Cogent Biosciences (COGT) and NeoGenomics (NEO)
American Well: Strategic DHA Contract Acknowledged Amid Hold Rating Pending Execution Proof
American Well: Hold Rating Amidst SaaS Deployment With DHA and Projected Financial Improvements
Truist Financial Maintains American Well(AMWL.US) With Hold Rating
American Well (AMWL) Gets a Hold From Truist Financial
American Well Analyst Ratings
American Well: Hold Rating Affirmed Amid Cost Management Improvements and Revenue Growth Challenges
Wells Fargo Maintains American Well(AMWL.US) With Hold Rating, Cuts Target Price to $15
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF) and American Well (AMWL)
A Quick Look at Today's Ratings for American Well(AMWL.US), With a Forecast Between $9 to $20
American Well Analyst Ratings
A Quick Look at Today's Ratings for American Well(AMWL.US), With a Forecast Between $9 to $12
Analysts Offer Insights on Healthcare Companies: American Well (AMWL), United Therapeutics (UTHR) and NeoGenomics (NEO)